Pharmacy supply in the UK and the questions you will be asked posts 91–106

Answering the question post #87 raises rather than the one it answers.

Clinical guidance published for prescribers is public and answers most eligibility questions here more precisely than the discussion does.

Stating my assumptions rather than smuggling them in.

Importing for personal use: importing a prescription-only medicine without a prescription is not lawful. Material sold as research-use-only is not a licensed medicine regardless of content.

One case, stated as one case.

Understood. Thank you for being specific about the limits of it.

Two claims get bundled together under pharmacy supply and they need separating. The descriptive one — this is what was observed — is usually well supported. The causal one — this is why — usually is not.

Almost every disagreement in threads like this one dissolves once you say which of the two you are making.

Post #91 describes the usual case. This is about the unusual one.

I disagree with the framing of pharmacy supply above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it can be checked.

The reasoning depends on an assumption that is doing a lot of work and is never stated. If the assumption holds, the conclusion follows. I do not think it holds generally.

Adding the measurement that post #95 says would settle it.

Pharmacy practice varies between pharmacies and is not deducible from the regulatory position. Two people can honestly report opposite experiences.

A request rather than an answer: could whoever has the primary source for pharmacy supply post it? I have seen the claim three times this month and each version had lost a qualifier.

Nothing in this subcategory is medical or legal advice, and prescribers reading here consistently say so themselves.

Worth saying I have only my own numbers here, and n is small.

I keep a log for pharmacy supply specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing and settled it.

I will take the caveat as seriously as the claim, which is the point of putting it there.

Shortage positions have moved several times and any statement about supply here should carry a date on the face of it.

The disagreement above is smaller than it looks once the terms are fixed.

Taking post #99 at face value and following it one step further.

Two sentences on pharmacy supply and then I will stop, because the rest is speculation and the thread is better without mine.

What is documented is narrow. What is inferred from it is broad. The gap between them is where every argument here lives.

Everything in post #99 holds. The case it does not cover is the one I have.

Compounding pharmacies: UK allows compounding under specific conditions when a licensed product is unavailable. That is not a front-line option but becomes relevant during shortages.

It is worth checking rather than assuming, which costs nothing.

One caution on pharmacy supply: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is rarely stated.